Editorial: The gut-liver axis: the main role of microbiome in liver diseases

Editorial: The gut-liver axis: the main role of microbiome in liver diseases

Saved in:

Bibliographic Details
Main Authors:	Giovanni Tarantino, Tiziana Di Renzo, Mauro Cataldi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-03-01
Series:	Frontiers in Microbiology
Subjects:	gut-liver axis microbiome & dysbiosis intestinal permeability liver disease NAFLD
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2025.1567513/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Deciphering the Gut–Liver Axis: A Comprehensive Scientific Review of Non-Alcoholic Fatty Liver Disease
by: Samradhi Singh, et al.
Published: (2024-09-01)

Gut microbiome in non-alcoholic fatty liver disease
by: Anastasios Mpountouridis, et al.
Published: (2025-01-01)

From Dysbiosis to Hepatic Inflammation: A Narrative Review on the Diet-Microbiota-Liver Axis in Steatotic Liver Disease
by: Andrea Pasta, et al.
Published: (2025-01-01)

Gut microbiome and liver diseases
by: Jun Xu, et al.
Published: (2025-03-01)

Unveiling the distinctive gut microbiota and metabolites in liver cirrhosis and its complications: Novel diagnostic biomarkers: Editorial on “Gut microbiome and metabolome signatures in liver cirrhosis-related complications”
by: Soon Kyu Lee, et al.
Published: (2025-01-01)

Research Progress in Microbe-Gut-Liver Axis and Alcoholic Liver Disease and Nutritional Interventions for It
by: ZHENG Hongxing, JI Le, QI Shanshan
Published: (2024-10-01)

Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Emidio Scarpellini, et al.
Published: (2024-11-01)

Deciphering the role of dietary modifications and gut dysbiosis in Non-Alcoholic Fatty Liver Disease
by: Meenakshi Vachher, et al.
Published: (2025-06-01)

Air-Pollution-Mediated Microbial Dysbiosis in Health and Disease: Lung–Gut Axis and Beyond
by: Md Habibul Hasan Mazumder, et al.
Published: (2024-10-01)

Low-dose polystyrene microplastics exposure increases susceptibility to obesity-induced MASLD via disrupting intestinal barrier integrity and gut microbiota homeostasis
by: Gang Wei, et al.
Published: (2025-07-01)

Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Pathogenic Mechanisms and Therapeutic Implications
by: Farah Abdelhameed, et al.
Published: (2025-03-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes
by: Ankita Dua, et al.
Published: (2025-08-01)

Exploring the alleviating effects of Bifidobacterium metabolite lactic acid on non-alcoholic steatohepatitis through the gut-liver axis
by: Hongmei Zhao, et al.
Published: (2025-01-01)

Cholesterol and the gut-liver axis: unraveling their role in the onset and progression of metabolic-associated steatotic liver disease
by: Luis A. Rodríguez-Rojas, et al.
Published: (2025-08-01)

Correspondence to editorial on: “Gut microbiome and metabolome signatures in liver cirrhosis-related complications”
by: Satya Priya Sharma, et al.
Published: (2025-01-01)

The Intestinal Thread of Fate: How the Microbiota Shapes the Story of Liver Disease
by: Carlo Acierno, et al.
Published: (2025-04-01)

Gut microbiota-mediated gut-liver axis: a breakthrough point for understanding and treating liver cancer
by: Chenyang Li, et al.
Published: (2025-04-01)

Distinct clusters of bacterial and fungal microbiota in end-stage liver cirrhosis correlate with antibiotic treatment, intestinal barrier impairment, and systemic inflammation
by: Laura Buttler, et al.
Published: (2025-12-01)

Exploring the role of gut microbiota in colorectal liver metastasis through the gut-liver axis
by: Qiu-Luo Liu, et al.
Published: (2025-03-01)

Gut Microbiota and the Gut–Liver Axis in Liver Disease: From Chronic Viral Hepatitis to Cirrhosis, Hepatocellular Carcinoma, and Microbiome-Based Therapies
by: Sniedze Laivacuma, et al.
Published: (2025-04-01)

Integrated Microbiome–Metabolome Analysis Reveals Intestine–Liver Metabolic Associations in the Moustache Toad
by: Shui-Sheng Yu, et al.
Published: (2025-07-01)

Pathogenic aspects of fructose consumption in metabolic dysfunction-associated steatotic liver disease (MASLD): A narrative review
by: Katharina Burger, et al.
Published: (2025-06-01)

A decrease in functional microbiomes represented as Faecalibacterium affects immune homeostasis in long-term stable liver transplant patients
by: Soon Kyu Lee, et al.
Published: (2022-12-01)

Editorial: Innovative multidisciplinary insights into the gut-liver axis and cancer
by: Rohit Gundamaraju, et al.
Published: (2025-04-01)

Chronic chlorothalonil exposure inhibits locomotion and interferes with the gut-liver axis in Pelophylax nigromaculatus tadpoles
by: Minyi Huang, et al.
Published: (2025-04-01)

The newly proposed dietary index for gut microbiota and its association with the risk of nonalcoholic fatty liver disease: the mediating role of body mass index
by: Shengnan Meng, et al.
Published: (2025-06-01)

Gut microbiota and the “gut-liver-kidney axis” theory: from mechanisms to therapeutics
by: Dai-Liang Fei, et al.
Published: (2025-06-01)

Intestinal Microbiota Modulation by Fecal Microbiota Transplantation in Nonalcoholic Fatty Liver Disease
by: Goran Hauser, et al.
Published: (2025-03-01)

Leaky Gut Biomarkers as Predictors of Depression and Suicidal Risk: A Systematic Review and Meta-Analysis
by: Donato Morena, et al.
Published: (2025-07-01)

Thiacloprid exposure disrupts the gut-liver axis and induces liver dysfunction in the Reeves' turtles (Mauremys reevesii)
by: Shuqin Lin, et al.
Published: (2025-01-01)

Probiotics for the treatment of hyperlipidemia: Focus on gut-liver axis and lipid metabolism
by: Min You, et al.
Published: (2025-04-01)

From gut to liver: Exploring the crosstalk between gut-liver axis and oxidative stress in metabolic dysfunction-associated steatotic liver disease
by: Mi Zhou, et al.
Published: (2025-01-01)

Microbiome-derived bile acids as endogenous regenerative mediators in liver repair
by: Surya Nath Pandey, et al.
Published: (2025-12-01)

The Interplay between Liver and Adipose Tissue in the Onset of Liver Diseases: Exploring the Role of Vitamin Deficiency
by: Ivan Tattoli, et al.
Published: (2024-09-01)

Gut Microbiota as Emerging Players in the Development of Alcohol-Related Liver Disease
by: Wei Li, et al.
Published: (2024-12-01)

Editorial: The microbiome-gut-brain axis and posttraumatic stress disorder
by: Robin M. Voigt, et al.
Published: (2025-04-01)

Bacterial extracellular vesicles: emerging mediators of gut-liver axis crosstalk in hepatic diseases
by: Yutong Zhou, et al.
Published: (2025-06-01)

Unraveling the Role of the Human Gut Microbiome in Health and Diseases
by: Mohamad Khalil, et al.
Published: (2024-11-01)

Dietary intervention with Polygonatum sibiricum polysaccharides mitigates cadmium liver toxicity: a gut-liver axis perspective
by: Qiannan Di, et al.
Published: (2025-07-01)

Gentiopicroside improves DSS-induced ulcerative colitis and secondary liver injury in mice by enhancing the intestinal barrier and regulating the gut microbiome
by: Liu Cao, et al.
Published: (2025-07-01)